Pharmacokinetic modeling to support dosing of Teduglutide in pediatric patients with short bowel syndrome

Trial Profile

Pharmacokinetic modeling to support dosing of Teduglutide in pediatric patients with short bowel syndrome

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Apr 2017

At a glance

  • Drugs Teduglutide (Primary)
  • Indications Short bowel syndrome
  • Focus Pharmacokinetics
  • Most Recent Events

    • 08 Apr 2017 New trial record
    • 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top